Ritonavir Tablet
Product Images NDC 69097-655

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Ritonavir (NDC 69097-655). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (127233bc Ed5c 470a Bc45 3313b08346b7 01)

Image (127233bc Ed5c 470a Bc45 3313b08346b7 01)
This text is a mathematical formula that calculates BSA (Body Surface Area) using the height in centimeters and weight in kilograms. It is not possible to provide a more descriptive explanation without further context.*
FDA Label Image

Image (127233bc Ed5c 470a Bc45 3313b08346b7 02)

FDA Label Image

Label-30's (127233bc Ed5c 470a Bc45 3313b08346b7 03)

Label-30's (127233bc Ed5c 470a Bc45 3313b08346b7 03)
This text describes the usage instructions and storage details of Ritonavir tablets, which contain 100mg of Ritonavir USP. Patients are advised to take the tablets with meals, not crush or chew them, and follow the dosage instructions provided in the package insert. The tablets should be stored at or below room temperature, and exposure to high humidity or temperatures above 50°C for more than seven days is not recommended. It is suggested to dispense the tablets in the original container or an equivalent container with a capacity of 60 mL or less. Pharmacists are also instructed not to cover the ALERT box on the package label. There is a serial number for the batch overprinting area, and a lot number mentioned in the text.*
FDA Label Image

Ritonavir Tablets 100 mg Carton (127233bc Ed5c 470a Bc45 3313b08346b7 04)

Ritonavir Tablets 100 mg Carton (127233bc Ed5c 470a Bc45 3313b08346b7 04)
This is a description of a medication called Ritonavir Tablets. Each film-coated tablet contains 100 mg of ritonavir USP. The tablets should be swallowed whole and taken with meals. They should not be chewed, broken, or crushed. The usual dosage information is included in the package insert. The tablets should be stored at or below 30°C (86°F) and exposure to temperatures up to 50°C (122°F) for seven days is permitted. Dispense in the original container or USP equivalent tight container (60 mL or less). There is an ALERT box that the pharmacist should not cover with pharmacy label. The package insert is provided for tear-off patient information. It is important to find out about medicines that should NOT be taken with Ritonavir Tablets, and there is a code to be entered to find out more about this. The batch number, expiry, and lot will be overprinted during commercial packing. The label size is 100 x 40 mm, and the colors are PANTONE 2945 C, PANTONE 199 C, and PANTONE Black C. The manufacturing company is Cipla Ltd., located in MIDC Patalganga, India.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.